Beloit Health System Performs Groundbreaking FARAPULSE Procedure to Treat Life-Threatening Arrhythmia

Beloit Health System Performs Groundbreaking Farapulse Procedure to Treat Life-Threatening Arrhythmia

Beloit Health System is proud to announce that it has successfully performed its first Farapulse procedure, a revolutionary treatment for patients suffering from paroxysmal atrial fibrillation (AFib). Beloit Health System is only one of three hospitals in Wisconsin that have the technology and expertise to perform this procedure.

The Farapulse Pulsed Field Ablation (PFA) System is a catheter device that uses non-thermal electric fields to target and treat specific myocardial cells in the heart that cause potentially life-threatening arrhythmias. This is all achieved while sparing the normal surrounding myocardial tissue. This minimally invasive procedure offers patients a safe and effective alternative to traditional thermal ablation therapies.

The successful procedure was performed by Dr. Sra and the cardiology cathlab/EP team on Thursday, June 13, 2024. "We are thrilled to be one of the first hospitals in Wisconsin to offer this groundbreaking technology," said Michelle Tyler, Director of Cardiology. "The Farapulse System has shown tremendous promise in treating patients with drug-refractory atrial fibrillation, and we are excited to offer this innovative procedure to our patients."

The Farapulse procedure uses a catheter device to deliver a non-thermal pulsed electrical field to allow for precise and targeted treatment of the arrhythmia-causing areas. This minimizes the risk of complications and reduces the need for further procedures.

"We are committed to providing our patients with access to the latest technologies and treatments," said Nommo Donald, Vice President of Beloit Health System. "The Farapulse System is a game-changer in the field of electrophysiology, and we are proud to be at the forefront of this innovation in Wisconsin."